key: cord-0772684-01uipvl5 authors: Sebastião, Cruz S.; Gaston, Celestina; Paixão, Joana Paula; Sacomboio, Euclides N. M.; Neto, Zoraima; de Vasconcelos, Jocelyne Neto; Morais, Joana title: Coinfection between SARS‐CoV‐2 and vector‐borne diseases in Luanda, Angola date: 2021-09-27 journal: J Med Virol DOI: 10.1002/jmv.27354 sha: 0abc76c77bdbdd41bbebce52592d17e474145ffe doc_id: 772684 cord_uid: 01uipvl5 Co‐epidemics happening simultaneously can generate a burden on healthcare systems. The co‐occurrence of SARS‐CoV‐2 with vector‐borne diseases (VBD), such as malaria and dengue in resource‐limited settings represents an additional challenge to the healthcare systems. Herein, we assessed the coinfection rate between SARS‐CoV‐2 and VBD to highlight the need to carry out an accurate diagnosis and promote timely measures for these infections in Luanda, the capital city of Angola. This was a cross‐sectional study conducted with 105 subjects tested for the SARS‐CoV‐2 and VBD with a rapid detection test in April 2021. The participants tested positive for SARS‐CoV‐2 (3.80%), malaria (13.3%), and dengue (27.6%). Low odds related to testing positivity to SARS‐CoV‐2 or VBD were observed in participants above or equal to 40 years (odds ratio [OR]: 0.60, p = 0.536), while higher odds were observed in male (OR: 1.44, p = 0.392) and urbanized areas (OR: 3.78, p = 0.223). The overall co‐infection rate between SARS‐CoV‐2 and VBD was 11.4%. Our findings showed a coinfection between SARS‐CoV‐2 with malaria and dengue, which could indicate the need to integrate the screening for VBD in the SARS‐CoV‐2 testing algorithm and the adjustment of treatment protocols. Further studies are warranted to better elucidate the relationship between COVID‐19 and VBD in Angola. This was a cross-sectional study performed with 105 tested for the SARS-CoV-2, malaria, and dengue in April 2021 at Instituto Nacional de Investigação em Saúde (INIS), located in Luanda. The INIS is an Angolan institute of scientific research whose main objective is to generate, develop and disseminate scientific, technological, and strategic knowledge about health and its determinants (http://www.inis.ao/index.php/ institucional/o-instituto). The study protocol received ethical approval from the National Ethics Committee of the Ministry of Health of Angola (nr.25/2020). Even so, after clarifying the project to the participants, we request free and unwritten oral authorization from participants or their legal guardians for minors under 18 before being enrolled in the study, which was registered in the data collection questionnaire of each participant. All the information obtained was fully anonymized, used only for this project, and kept confidential. The sociodemographic characteristics such as age, gender, and residence area of participants were collected by the research team using a structured questionnaire developed as part of this study. The questionnaire was not validated before testing on study participants. Additionally, an estimated volume of 5 ml of intravenous whole blood was collected from each participant in a tube containing ethylenediaminetetraacetic acid (EDTA). The collected samples were subjected to rapid detection tests (RDT) targeting the qualitative detection of SARS-CoV-2 (COVID-19 IgG/IgM Rapid Test Device; Abbott), Plasmodium (Malaria Ag P.f/P.v; MT Promedt), and dengue virus (DENV) (SD Bioline Dengue IgG/IgM), following the instructions provided by the manufacturers. According to the manufacturer's instructions, the tests were considered positive when the two lines of any intensity appeared in the patient's control and test areas. On the other hand, tests that presented only one line in the control area and no lines in the patient area were considered negative. All invalid results were re-tested. Participants who tested positive for immunoglobulin G (IgG) or immunoglobulin (IgM) antibodies were coded as positive, whereas participants who tested negative for either IgG or IgM were coded as negative. No external samples known to be positive for SARS-CoV-2, malaria, or dengue, were used as an external control for the rapid diagnostic kits used in this study. In addition, positive samples for dengue were subjected to molecular screening. Briefly, total viral ribonucleic acid (RNA) was manually extracted from 140 µl using the QIAamp Viral RNA kit (QIAGEN) and stored at −80°C until further analysis. After that, the presence of DENV RNA was screened using real-time reverse-transcription polymerase chain reaction (RT-PCR) with the Applied Biosystems The data were analyzed in SPSS v26 (IBM SPSS Statistics). Frequencies and percentages were presented as descriptive analyses. Mean and the standard deviation (SD) were presented to the normal distribution data. X 2 test and logistic regression were applied to check interactions between dichotomized variables. The odds ratio (OR) with 95% confidence intervals (CIs) was also calculated. The reported p-values are two-tailed and deemed significant when p < 0.05. The putative sociodemographic characteristics related to SARS-CoV-2 and VBD in Luanda, are summarized in Table 1 . This study included a The rate of coinfection between SARS-CoV-2 and VBD is shown in The COVID-19 pandemic triggered extra pressure on public health systems, with a higher threat in endemic regions with infections transmitted by arthropod bites. Simultaneously with SARS-CoV-2, VBD also continues to spread, particularly in tropical regions. [6] [7] [8] Angola is endemic for malaria and arboviruses such as dengue, Zika, and chikungunya, [14] [15] [16] however, the possibility of cocirculation and SARS-CoV-2/VBD co-infection in hyperendemic regions with these infectious agents exists and must be monitored. 9 To the best of our knowledge, this is the first study assessing the coinfection between SARS-CoV-2 and VBD in Angola. So far, no significant effort has been made to describe the coinfection situations between SARS-CoV-2 and VBD in tropical, subtropical, and temperate regions. 19 The overlapping incidence of COVID-19, malaria, dengue, Zika, and chikungunya could hinder the patient's timely diagnosis, treatment as well as disease prevention, in part due to some similarity of clinical symptoms. 20 Early clinical symptoms (e.g., fever, chills, headache, fatigue, and myalgia) and laboratory parameters infection as well as its aspects are still to be discovered. The SARS-CoV-2 reactivity rate observed in this study (3.8%) ( We identified about 13% for malaria and 28% for dengue in our study sample (Table 1) . Overall, about 33% of the study participants had some VBD ( Table 2 ). The rate of VBD observed in this population is not surprising, as Luanda is an endemic region with diseases transmitted by arthropod bites, such as malaria and dengue fever. 15 In the last 20 years, the global burden of malaria has reduced, mainly with the distribution of insecticide-treated bednets, indoor spraying of residual insecticides, access to early diagnosis, and the availability of more effective antimalarial treatments. 22 However, as the COVID-19 pandemic has become a priority for public health agendas in so many countries around the world, it caused a devastating impact on other diseases, like malaria, which became apparent, especially in endemic regions with a high level of mortality from malaria, such as in Angola. 23 To reduce the impact of the COVID-19 pandemic on the increase in malaria cases and mortality, the provision of diagnoses, treatments, and other preventive interventions must be maintained while facing the COVID-19 response. 24 13 where was not observed an indication that dengue fever could protect patients from SARS-CoV-2. Our results have severe limitations. This is a preliminary study in a small sample size that does not represent the whole population from Luanda or other regions of Angola, therefore further studies with a wide population need to be considered. Also, serological tests for dengue are known to be affected by cross-reactivity with other Flavivirus, such as Zika or yellow fever, which increases the risk of false positives results. 11, 12 Therefore, NS1 antigen screening should be assessed, but, due to resource constraints for this project, it was In summary, our findings showed that the VBD endemic circulation could add more pressure on health systems already overburdened during the COVID-19 pandemic period, mainly in a resource-limited setting. Thus, we suggest that patients with COVID-19-related symptoms should also be screened for VBD and vice versa, in an effort to initiate the tailoring of treatment protocols in cases of coinfection. We call on researchers to conduct further studies on VBD within the context of the COVID-19 pandemic in Angola. Epidemiology of covid-19 Disruption of childhood vaccination during the COVID-19 pandemic in Indonesia Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: a systematic review and meta-analysis A pneumonia outbreak associated with a new coronavirus of probable bat origin COVID-19 weekly epidemiological update 35. WHO Covid-19, chikungunya, dengue and zika diseases: an analytical platform based on MALDI-TOF MS, ir spectroscopy and RT-qPCR for accurate diagnosis and accelerate epidemics control Malaria and COVID-19: unmasking their ties Malaria and covid-19: common and different findings Covid-19 and dengue: double punches for dengue-endemic countries in Asia A patient with dengue fever and COVID-19: coinfection or not? Cureus Low risk of serological cross-reactivity between dengue and COVID-19 Serological crossreaction and coinfection of dengue and COVID-19 in Asia: experience from Indonesia Clinical and biochemical parameters of COVID-19 patients with prior or active dengue fever Emergence of the Asian lineage of Zika virus in Angola: an outbreak investigation Inquérito de Indicadores Múltiplos e de Saúde Early genomic detection of cosmopolitan genotype of dengue virus serotype 2, Angola Performance of the Trioplex real-time RT-PCR assay for detection of Zika, dengue, and chikungunya viruses Trioplex real-time RT-PCR assay Sars-cov-2 and arbovirus infection: a rapid systematic review Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever Sociodemographic characteristics and risk factors related to SARS-CoV-2 infection in Luanda The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015 COVID-19 and the impact on malaria Identifying and combating the impacts of COVID-19 on malaria Virology, epidemiology, pathogenesis, and control of COVID-19 How super-spreader cities, highways, hospital bed availability, and dengue fever influenced the COVID-19 epidemic in Brazil. medRxiv. 2020. How to cite this article The authors are grateful to all study participants. We also thank the The authors declare that there are no conflict of interests. Conceptualization, investigation, methodology, and validation: Cruz S. The data that support the findings of this study are available on request from the corresponding author.